Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02915263
Recruitment Status : Recruiting
First Posted : September 27, 2016
Last Update Posted : July 15, 2020
Sponsor:
Collaborator:
Grifols Biologicals, LLC
Information provided by (Responsible Party):
Christopher Gibbons, MD, Beth Israel Deaconess Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : September 2021
Publications: